A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab
一项针对恶性胸膜疾病患者的区域性间皮素靶向CAR-T细胞疗法联合抗PD-1药物帕博利珠单抗的I期临床试验
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-21-0407
Adusumilli, Prasad S; Zauderer, Marjorie G; Rivière, Isabelle; Solomon, Stephen B; Rusch, Valerie W; O'Cearbhaill, Roisin E; Zhu, Amy; Cheema, Waseem; Chintala, Navin K; Halton, Elizabeth; Pineda, John; Perez-Johnston, Rocio; Tan, Kay See; Daly, Bobby; Araujo Filho, Jose A; Ngai, Daniel; McGee, Erin; Vincent, Alain; Diamonte, Claudia; Sauter, Jennifer L; Modi, Shanu; Sikder, Devanjan; Senechal, Brigitte; Wang, Xiuyan; Travis, William D; Gönen, Mithat; Rudin, Charles M; Brentjens, Renier J; Jones, David R; Sadelain, Michel